On behalf of Prof. Yvonne Alexander, I would like to extend to you, and to your associates, an invitation to the following event:
From Gene Therapy to Precision Medicine: A Scientific Journey. A talk by Prof. Yvonne Alexander on Thursday 22nd June at 18:00 in C0.14, John Dalton building. (Refreshments available from 17:30).
We are witnessing a rising epidemic in obesity and diabetes, which increases the risk of cardiovascular disease, one of the biggest killers in our society. I will discuss some of the milestones since the early ‘90s, when the birth of molecular biology, DNA technology and cell biology methods have been expanded and leads us to the most important concept to emerge in 21st century clinical science, that of personalised medicine.
This talk will cover how cells communicate with each other in this disease process, how they change their behaviour from good to bad during the development of disease and how we can translate our cellular knowledge into novel treatments in the future. Vascular biology is now at the forefront of basic and translational research due to its interdisciplinary significance, which will be a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new treatments.
Yvonne Alexander graduated in Biology from Strathclyde University in 1987 and her early career in The University of Glasgow was founded on her PhD studies in the CRC Beatson Institute, followed by post-doctoral studies in the Depts of Genetics and Medicine and Therapeutics, when she gained her transferable skills in transgenic technology and adenoviral gene transfer to study disease mechanisms.
Yvonne’s interest in vascular disease continued with a move to the University of Manchester as a Lecturer and then senior lecturer in Molecular Medicine, before taking up a Professorial position in Translational Science in Manchester Met in 2013 and is now Head of the vascular pathology group in the Centre for Biomedicine. Her research programme aims to understand vascular disease mechanisms and identify novel biomarkers of disease, thereby contributing to patient stratification and application of personalized medicine. She is a past Chair of the British Society for Cardiovascular Research and is the current President of The European Vascular Biology Organisation.
Refreshments will be available from 17:30 in MMU’s John Dalton building, with the talk beginning in Lecture Theatre C0.14 at 18:00. This will last around one hour and will include time for audience questions. The event will finish with a drinks reception and further discussion.
Attendance to this event is free of charge, however we do ask that you book tickets in advance at https://profyvonnealexander.eventbrite.co.uk
For queries related to this event or any others organised by MMU Engage, please email: email@example.com.